-
hcup-us.ahrq.gov/reports/statbriefs/sb169-Asthma-Trends-Hospital-Stays.pdf
August 01, 2013 - HCUP data include
obstetrics and gynecology, otolaryngology, orthopedic, cancer, pediatric, public,
-
hcup-us.ahrq.gov/reports/statbriefs/sb122.jsp
October 01, 2011 - HCUP includes data from OB-GYN, ENT, orthopedic, cancer, pediatric, public, and academic medical hospitals
-
hcup-us.ahrq.gov/reports/statbriefs/sb85.pdf
January 01, 2010 - HCUP data
include OB-GYN, ENT, orthopedic, cancer, pediatric, public, and academic medical hospitals
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017270-fricton-final-report-2011.pdf
January 01, 2011 - Chronic illnesses such as heart disease, diabetes, cancer, and lung disease comprise most illnesses … Furthermore, cancer
radiation therapy on or near the salivary glands can temporarily or permanently
-
www.ahrq.gov/practiceimprovement/systemdesign/leancasestudies/lean-case6.html
November 01, 2014 - In addition, a cancer program provides cancer patients with access to comprehensive treatment.
-
www.ahrq.gov/sites/default/files/2024-11/ridley-report.pdf
January 01, 2024 - Center for Patient Safety, Dana-Farber Cancer Institute
Jie Zheng, Ph.D. … either due to duplication (one hospital), specialty hospital status (five
hospitals - pediatrics, cancer
-
www.ahrq.gov/sites/default/files/publications/files/ccreroadmap.pdf
July 01, 2013 - While the IOM report addressed primary
care and public health integration efforts for colorectal cancer … National Cancer Institute
Cheryl Irmiter, Ph.D., L.C.S.W., CADC
Easter Seals
Robert Pestronk, M.P.H
-
digital.ahrq.gov/sites/default/files/docs/page/ahrq-health-information-technology-portfolio-2011-annual-report.pdf
January 01, 2011 - Medically Underserved 17
Not Applicable 17
Medicaid 16
Low-SES/Low Income 15
Hypertension 14
Safety Net 9
Cancer … Improving Quality in Cancer Screening: The
Excellence Report for Colonoscopy (Grant
# R18 HS 017017
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hhrqMCEgbsBMJ_Ppbcp4yJ
January 14, 2025 - does not ap-
ply to persons with secondary osteoporosis due to an underlying
medical condition (eg, cancer … They do not apply to persons with secondary osteoporosis due to an underlying medical condition (eg, cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - Duloxetine
and pregabalin in neuropathic pain of lung
cancer patients. … Br J Cancer. 2021
Apr;124(8):1379-87. doi: 10.1038/s41416-
021-01259-3. PMID: 33623076.
-
hcup-us.ahrq.gov/reports/methods/2011_01.pdf
January 01, 2011 - In addition, it might be appropriate to exclude patients with cancer or in an
immunocompromised state … Readmissions following pancreaticoduodenectomy for
pancreas cancer: a population-based appraisal.
-
effectivehealthcare.ahrq.gov/health-topics/antioxidants
-
effectivehealthcare.ahrq.gov/health-topics/quitting-smoking
-
effectivehealthcare.ahrq.gov/products/breast-abnormalities-tests-update/research
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
April 13, 2015 - screening was not associated with reduced risk for cardiovascular mortality (HR, 1.02 [CI, 0.75 to 1.38]), cancer-related … false-positive results
KQ 4: Serious side effects from treatments, including death, heart attack, stroke, cancer … : HR, 1.06 (95% CI, 0.90 to 1.25)
Cardiovascular mortality: HR, 1.02 (95% CI, 0.75 to 1.38)
Cancer
-
cdsic.ahrq.gov/sites/default/files/2025-03/SRF%20Standards%20for%20Patient%20Preferences.pdf
January 01, 2025 - were no standards identified for patient preferences in type of tests (e.g., preferred test
for colon cancer … term in Metathesaurus
Research/clinical trial use (e.g., data used to research new ways
to prevent cancer … The Stability of Treatment Preferences
Among Patients With Advanced Cancer.
-
effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
-
effectivehealthcare.ahrq.gov/products/ischemic-stroke-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
January 01, 2012 - Because it is a synthetic intestinal
growth factor, there has been some concern of malignancy, and … malignancies have been
observed in trial participants, although FDA has not requested any protocol … Additionally, three cases of cancer (a metastatic
adenocarcinoma of probable gastrointestinal origin … These malignancies were reviewed by an
independent safety review board that requested no changes to
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Maddox_111.pdf
June 18, 2008 - PCA therapy was initiated for a 56-year-old, 75-kg, Caucasian,
female patient with a history of lung cancer